Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 12/20 | 0.69 |
| ▸ | P2RX2 | Q9UBL9 | 11/20 | 0.69 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.47 |
| ▸ | MET | P08581 | 1/20 | 0.41 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3061491 | 1.00 | P2RX3 (0.69) | P2RX3P2RX2NR1I2CYP2C9UGT1A1 | |
| SCHEMBL2183696 | 0.82 | P2RX3 (0.63) | P2RX3P2RX2NR1I2CYP2C9UGT1A1 | |
| SCHEMBL21091896 | 0.82 | P2RX3 (0.56) | P2RX3P2RX2NR1I2 | |
| SCHEMBL3063281 | 0.81 | P2RX3 (1.00) | P2RX3P2RX2NR1I2CYP2C9UGT1A1 | |
| SCHEMBL13095503 | 0.80 | NR1I2 (0.50) | P2RX3P2RX2NR1I2CYP2C9UGT1A1 | |
| SCHEMBL3057997 | 0.76 | P2RX3 (0.63) | P2RX3P2RX2NR1I2CYP2C9UGT1A1 | |
| SCHEMBL3064190 | 0.75 | P2RX3 (0.62) | P2RX3P2RX2NR1I2CYP2C9UGT1A1 | |
| SCHEMBL13095460 | 0.75 | NR1I2 (0.47) | P2RX3P2RX2NR1I2CYP2C9UGT1A1 | |
| SCHEMBL13092766 | 0.74 | NR1I2 (0.48) | P2RX3P2RX2NR1I2CYP2C9UGT1A1 | |
| SCHEMBL3068648 | 0.72 | P2RX3 (0.50) | P2RX3P2RX2NR1I2CYP2C9UGT1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2215049-A1 | P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | Merck Sharp & Dohme Corp. (US) | 2010-08-11 | — | — | EP | claimed |
| WO-2009058298-A1 | P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | MERCK & CO., INC. (US) | 2009-05-07 | — | — | WO | claimed |